Migden, M., Lear, J., Squittieri, N., Liu, L., Guminski, A., & Dummer, R. (2020). Duration of Response and Progression-Free Survival with Sonidegib 200 Mg Once Daily Until Disease Progression or Start of New Antineoplastic Therapy in Patients with Locally Advanced Basal Cell Carcinoma: Results of the 42-Month, Randomized, Double-Blind. SKIN The Journal of Cutaneous Medicine, 4(5), s68. https://doi.org/10.25251/skin.4.supp.67